while preclinical studies suggest a steep dose-response relationship for the anti-cancer effect of recombinant interleukin-2 ( ril-2 ) , translation of dose-intense ril-2 to humans can be complicated by known toxicities , including hypotension , capillary leak phenomena and fluid retention .
C0021756
ril-2
C0086418
humans